StockWatch
·
Trading & Distributors
Board Meeting17 Oct 2026, 07:10 pm

Hemo Organic Ltd Board Approves Un-audited Financial Results

AI Summary

Hemo Organic Ltd announced that its Board of Directors met on October 17, 2026, to approve and take on record the un-audited standalone financial results for the quarter and half-year ended September 30, 2026. The meeting also included a review of the limited review report from the statutory auditors. Other routine business as per the agenda was also transacted. The company operates in a single segment, and disclosures under Ind AS 108 are not applicable.

Key Highlights

  • Board meeting held on October 17, 2026.
  • Approved un-audited standalone financial results for Q2 FY27.
  • Limited review report from statutory auditors taken on record.
  • Company operates in a single business segment.